glp-1 and insulin resistance Adipose Tissue: A Novel Target of the Incretin Axis? A Paradigm Shift in Obesity-Linked GLP-1 Therapy for Type 2

A., Ortiz, F., Varghese, T., Fabara, S

En el presente estudio, con el suplemento de L-carnitina, el valor del hematocrito en sangre tendi a disminuir numricamente, aunque no estadsticamente

For the wider class, SURMOUNT studied the dual agonist tirzepatide for weight management (NEJM 2022) and SURMOUNT-OSA studied tirzepatide for obstructive sleep apnea (NEJM 2024)

The integration of telehealth into the management of chronic conditions like diabetes, obesity, and weight management represents a meaningful advancement in modern healthcare

Notably, DTC telehealth models fit naturally with conditions requiring long-term management, such as type 2 diabetes and obesity